![]() |
New to the Huntington's Disease Lighthouse? |
||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HD Lighthouse Contributing Editor's Comment: As a major step towards treatments, HD researchers engineered mouse models of the disease by adding CAG repeats. Researchers Scott Zeitlin and Erin Clabough have now engineered a mouse without any CAG repeats in the region of the huntingtin's gene where excessive CAG repeats cause HD in people. The mice developed normally in utero unlike mice engineered to lack the huntingtin's gene altogether who die in utero. The huntingtin's protein is necessary for embryonic development, but the CAG repeats are not. In adulthood, however, the CAG-depleted mice exhibited mild memory and learning deficits but actually performed better on the rotarod, a standard measure of motor performance, than normal mice. The researchers suggest that the function of the CAG repeat is related to the regulation of energy within the cell. Examining cells in culture, they found that there were higher levels of ATP (adenosine triphosphate - cellular energy) present, but that the cells aged more quickly. As RNA interference technologies improve and advance toward human clinical trials, it is important for researchers to learn all they can about the normal function of the huntingtin's protein and the role of the CAG repeats. This study shows that developing a technique to knock out the CAG regions in the normal and HD gene would not be a good therapeutic strategy. -- Marsha L. Miller, Ph.D.
Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellularErin B.D. Clabough and Scott O. Zeitlin Source: Human Molecular Genetics 2006 15(4):607-623
|
Research focusing on the formation of aggregates caused by HD
Research related to the role Brain Derived Neurotrophic Factor has on the pathology of HD in the brain
Research related HD and it's general affect on the brain
Learn more about the clinical trial process, trials that have been conducted and those that are underway.
Research related to drugs and supplements that may delay onset and slow progression of Huntington's Disease.
Research focusing on gene therapy.
Research focusing on gene transcription.
Research studying the genetics of Huntington's Disease
Research studying the Immune System and it's effect on the progression of HD
Research studying the brain tissue and research related to stem cells
19 May 2008
New transgenic rhesus monkey model of HD developed
Emory University researchers have developed a new primate model of HD to study the disease and potential treatments. 16 Apr 2008
New Insights About Huntingtin Interacting Protein 1
Indiana researchers hope that examining the structure of huntingtin interacting proteins will uncover new information about HD. 10 Apr 2008
Exercise helps young HD mice
New research with the HD mice shows that starting exercise early helps delay the onset of motor symptoms. 24 Feb 2008
2008 CHDI HD Therapeutics Conference: A Report from an HD Family Perspective
Progress continues with CHDI's strategic efforts to develop treatments for Huntington's Disease. 1 Jan 2008
The Predict-HD Study Identifies Early Changes
The Predict-HD study has identified early, subtle, measurable changes that take place 10-20 years before diagnosis. 26 Jun 2007
High Q and Stem Cell Innovations, Inc. to Collaborate
HD specific human cell systems to be developed to improve drug discovery.
21 Jun 2007
Research Update from the 2007 HDSA convention: Part Two
Researchers report solid progress since the 2006 HDSA convention.
18 Jun 2007
Research Update from the 2007 HDSA Convention: Part One
Researchers report solid progress since last year.
29 Mar 2007
Young Adults Can Tell It Like It WAS!
The University of Iowa is asking for young adults to participate in a research study about growing up as a teenager in an HD family.
22 Feb 2007
A Report on the 2007 HD Therapeutics Conference
Significant research is taking place in all the disciplines that lead from basic research to an approved treatment.
All Updates for General | |||||||||||||||||||||
| Disclaimer & Privacy
Policy | |
|